Research Article

Awareness of and Preferences for Preexposure Prophylaxis (PrEP) among MSM at High Risk of HIV Infection in Southern China: Findings from the T2T Study

Table 2

Awareness, willingness, and preferences for oral and long-acting injectable HIV preexposure prophylaxis (PrEP) among MSM in southern China ().

VariablesResponse categoriesFrequencyPercentage (%)

Heard of PrEPNo31356.9
Yes23743.1
Willingness to use PrEPNo18834.2
Yes36265.8
Willingness to use daily oral PrEPNo20837.8
Yes34262.2
Willingness to use LAI-PrEPNo33861.5
Yes21238.5
Reasons for willingness to use PrEPaAt high risk of HIV infection6618.2
Partner/s at high risk of HIV infection369.9
To reduce risk30784.8
Other reasonsb164.4
Reasons for unwillingness to use PrEPaToo expensive7941.0
At low risk of HIV infection4322.3
Concerns about drug resistance3216.5
Trypanophobia147.4
Concerns about side-effects8243.1
Poor medication adherence4523.4
Other reasonsc3719.7
Adaptable frequency of using oral PrEPdNon-daily16147.1
Daily18152.9
Adaptable frequency of using LAI-PrEPdOnce every 3 or more months7535.4
Once every 2 months3215.1
Once a month10549.5

LAI: long-acting injectable; PrEP: preexposure prophylaxis. aMultiple-choice question. The number of participants who were willing to use PrEP was 362, and the opposite was 188. bOther reasons included curiosity and recommendation from friends. cOther reasons included job, family, and ease of suspicion. dThe number of participants who were willing to use oral PrEP was 342, and the number of participants who were willing to use LAI-PrEP was 212.